Annual Operating Expenses
$39.86 M
-$45.72 M-53.43%
30 June 2024
Summary:
MEI Pharma annual total operating expenses is currently $39.86 million, with the most recent change of -$45.72 million (-53.43%) on 30 June 2024. During the last 3 years, it has fallen by -$53.96 million (-57.52%). MEIP annual operating expenses is now -65.69% below its all-time high of $116.18 million, reached on 30 June 2022.MEIP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$8.35 M
+$271.00 K+3.35%
30 September 2024
Summary:
MEI Pharma quarterly total operating expenses is currently $8.35 million, with the most recent change of +$271.00 thousand (+3.35%) on 30 September 2024. Over the past year, it has dropped by -$1.66 million (-16.61%). MEIP quarterly operating expenses is now -73.28% below its all-time high of $31.25 million, reached on 31 March 2022.MEIP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -53.4% | -16.6% |
3 y3 years | -57.5% | -70.0% |
5 y5 years | -15.0% | -36.2% |
MEIP Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -65.7% | at low | -73.3% | +3.4% |
5 y | 5 years | -65.7% | at low | -73.3% | +3.4% |
alltime | all time | -65.7% | >+9999.0% | -73.3% | +4097.0% |
MEI Pharma Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $8.35 M(+3.4%) |
June 2024 | $39.86 M(-53.4%) | $8.08 M(-17.8%) |
Mar 2024 | - | $9.83 M(-17.6%) |
Dec 2023 | - | $11.93 M(+19.1%) |
Sept 2023 | - | $10.02 M(-20.1%) |
June 2023 | $85.58 M(-26.3%) | $12.54 M(-43.7%) |
Mar 2023 | - | $22.29 M(-6.4%) |
Dec 2022 | - | $23.81 M(-11.7%) |
Sept 2022 | - | $26.95 M(-2.4%) |
June 2022 | $116.18 M(+23.8%) | $27.61 M(-11.7%) |
Mar 2022 | - | $31.25 M(+6.1%) |
Dec 2021 | - | $29.46 M(+5.7%) |
Sept 2021 | - | $27.86 M(+21.5%) |
June 2021 | $93.81 M(+84.7%) | $22.93 M(-4.9%) |
Mar 2021 | - | $24.10 M(-13.5%) |
Dec 2020 | - | $27.87 M(+47.4%) |
Sept 2020 | - | $18.91 M(+52.7%) |
June 2020 | $50.78 M(+8.3%) | $12.39 M(-3.4%) |
Mar 2020 | - | $12.83 M(+2.8%) |
Dec 2019 | - | $12.48 M(-4.7%) |
Sept 2019 | - | $13.09 M(+11.2%) |
June 2019 | $46.90 M(+74.8%) | $11.78 M(-7.3%) |
Mar 2019 | - | $12.70 M(-1.4%) |
Dec 2018 | - | $12.89 M(+35.2%) |
Sept 2018 | - | $9.53 M(+37.9%) |
June 2018 | $26.82 M(+69.1%) | $6.91 M(+24.4%) |
Mar 2018 | - | $5.56 M(-4.2%) |
Dec 2017 | - | $5.80 M(-32.2%) |
Sept 2017 | - | $8.55 M(+119.3%) |
June 2017 | $15.87 M(-24.5%) | $3.90 M(-3.2%) |
Mar 2017 | - | $4.03 M(+11.5%) |
Dec 2016 | - | $3.61 M(-16.5%) |
Sept 2016 | - | $4.33 M(-25.7%) |
June 2016 | $21.00 M(-35.9%) | $5.82 M(+7.6%) |
Mar 2016 | - | $5.41 M(+5.5%) |
Dec 2015 | - | $5.13 M(+10.4%) |
Sept 2015 | - | $4.65 M(-18.3%) |
June 2015 | $32.77 M(+20.4%) | $5.69 M(-36.5%) |
Mar 2015 | - | $8.96 M(-1.7%) |
Dec 2014 | - | $9.12 M(+1.3%) |
Sept 2014 | - | $9.01 M(+5.2%) |
June 2014 | $27.23 M | $8.56 M(+15.6%) |
Mar 2014 | - | $7.41 M(+16.6%) |
Dec 2013 | - | $6.35 M(+29.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2013 | - | $4.91 M(+52.0%) |
June 2013 | $11.22 M(+33.7%) | $3.23 M(+16.8%) |
Mar 2013 | - | $2.77 M(+0.4%) |
Dec 2012 | - | $2.76 M(+11.8%) |
Sept 2012 | - | $2.47 M(+11.9%) |
June 2012 | $8.39 M(+30.1%) | $2.20 M(-4.3%) |
Mar 2012 | - | $2.30 M(+17.6%) |
Dec 2011 | - | $1.96 M(+1.2%) |
Sept 2011 | - | $1.93 M(+62.8%) |
June 2011 | $6.45 M(-19.2%) | $1.19 M(-10.8%) |
Mar 2011 | - | $1.33 M(-36.7%) |
Dec 2010 | - | $2.10 M(+14.9%) |
Sept 2010 | - | $1.83 M(-1.5%) |
June 2010 | $7.98 M(-30.1%) | $1.86 M(-16.8%) |
Mar 2010 | - | $2.23 M(+53.3%) |
Dec 2009 | - | $1.46 M(-40.2%) |
Sept 2009 | - | $2.43 M(-55.4%) |
June 2009 | $11.41 M(-17.1%) | $5.45 M(+182.0%) |
Mar 2009 | - | $1.93 M(+15.4%) |
Dec 2008 | - | $1.68 M(-28.6%) |
Sept 2008 | - | $2.35 M(-43.7%) |
June 2008 | $13.76 M(-4.9%) | $4.17 M(+19.7%) |
Mar 2008 | - | $3.48 M(+37.8%) |
Dec 2007 | - | $2.52 M(-29.5%) |
Sept 2007 | - | $3.58 M(+63.0%) |
June 2007 | $14.46 M(+95.9%) | $2.20 M(+16.1%) |
Mar 2007 | - | $1.89 M(-19.7%) |
Dec 2006 | - | $2.36 M(-70.6%) |
Sept 2006 | - | $8.02 M(+3927.6%) |
June 2006 | $7.38 M(+15.0%) | $199.00 K(-94.1%) |
Mar 2006 | - | $3.35 M(+75.7%) |
Dec 2005 | - | $1.91 M(-0.9%) |
Sept 2005 | - | $1.93 M(-1.5%) |
June 2005 | $6.42 M(-24.8%) | $1.96 M(+8.0%) |
Mar 2005 | - | $1.81 M(+25.9%) |
Dec 2004 | - | $1.44 M(+10.9%) |
Sept 2004 | - | $1.30 M(+20.1%) |
June 2004 | $8.54 M(+218.8%) | $1.08 M(-33.2%) |
Mar 2004 | - | $1.62 M(-65.5%) |
Dec 2003 | - | $4.68 M(+312.5%) |
Sept 2003 | - | $1.14 M(+58.3%) |
June 2003 | $2.68 M(+1976.0%) | $717.00 K(+13.3%) |
Mar 2003 | - | $633.00 K |
June 2002 | $129.00 K | - |
FAQ
- What is MEI Pharma annual total operating expenses?
- What is the all time high annual operating expenses for MEI Pharma?
- What is MEI Pharma annual operating expenses year-on-year change?
- What is MEI Pharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for MEI Pharma?
- What is MEI Pharma quarterly operating expenses year-on-year change?
What is MEI Pharma annual total operating expenses?
The current annual operating expenses of MEIP is $39.86 M
What is the all time high annual operating expenses for MEI Pharma?
MEI Pharma all-time high annual total operating expenses is $116.18 M
What is MEI Pharma annual operating expenses year-on-year change?
Over the past year, MEIP annual total operating expenses has changed by -$45.72 M (-53.43%)
What is MEI Pharma quarterly total operating expenses?
The current quarterly operating expenses of MEIP is $8.35 M
What is the all time high quarterly operating expenses for MEI Pharma?
MEI Pharma all-time high quarterly total operating expenses is $31.25 M
What is MEI Pharma quarterly operating expenses year-on-year change?
Over the past year, MEIP quarterly total operating expenses has changed by -$1.66 M (-16.61%)